Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC.
Schmitz FJ, Jones ME, Hofmann B, Hansen B, Scheuring S, Lückefahr M, Fluit A, Verhoef J, Hadding U, Heinz HP, Köhrer K. Schmitz FJ, et al. Among authors: scheuring s. Antimicrob Agents Chemother. 1998 May;42(5):1249-52. doi: 10.1128/AAC.42.5.1249. Antimicrob Agents Chemother. 1998. PMID: 9593159 Free PMC article.
Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus.
Schmitz FJ, Hofmann B, Hansen B, Scheuring S, Lückefahr M, Klootwijk M, Verhoef J, Fluit A, Heinz HP, Köhrer K, Jones ME. Schmitz FJ, et al. Among authors: scheuring s. J Antimicrob Chemother. 1998 Apr;41(4):481-4. doi: 10.1093/jac/41.4.481. J Antimicrob Chemother. 1998. PMID: 9598779
Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains.
Schmitz FJ, Hertel B, Hofmann B, Scheuring S, Verhoef J, Fluit AC, Heinz HP, Köhrer K, Jones ME. Schmitz FJ, et al. Among authors: scheuring s. J Antimicrob Chemother. 1998 Oct;42(4):561-3. doi: 10.1093/jac/42.4.561. J Antimicrob Chemother. 1998. PMID: 9818767 No abstract available.
Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins.
Brisse S, Milatovic D, Fluit AC, Verhoef J, Martin N, Scheuring S, Köhrer K, Schmitz FJ. Brisse S, et al. Among authors: scheuring s. Antimicrob Agents Chemother. 1999 Aug;43(8):2051-5. doi: 10.1128/AAC.43.8.2051. Antimicrob Agents Chemother. 1999. PMID: 10428935 Free PMC article.
Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory season.
Jones ME, Sahm DF, Martin N, Scheuring S, Heisig P, Thornsberry C, Köhrer K, Schmitz FJ. Jones ME, et al. Among authors: scheuring s. Antimicrob Agents Chemother. 2000 Feb;44(2):462-6. doi: 10.1128/AAC.44.2.462-466.2000. Antimicrob Agents Chemother. 2000. PMID: 10639387 Free PMC article.
Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates.
Schmitz FJ, Fluit AC, Hafner D, Beeck A, Perdikouli M, Boos M, Scheuring S, Verhoef J, Köhrer K, Von Eiff C. Schmitz FJ, et al. Among authors: scheuring s. Antimicrob Agents Chemother. 2000 Nov;44(11):3229-31. doi: 10.1128/AAC.44.11.3229-3231.2000. Antimicrob Agents Chemother. 2000. PMID: 11036061 Free PMC article.
164 results